TipRanks
Shivalik Rasayan Ltd (IN:SHIVALIK)
:SHIVALIK
India Market
Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis

0 Followers

Top Page

IN:SHIVALIK

Shivalik Rasayan Ltd

(SHIVALIK)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - Gpt-5.6Sol)
Rating:60Neutral
Price Target:
₹430.00
▲(19.86% Upside)
Action:Reiterated
Date:09/17/26
The score is capped primarily by weak cash generation (negative operating and free cash flow) despite a solid, low-leverage balance sheet and steady revenue growth. Technicals are a meaningful positive with strong trend and momentum, but valuation is a clear headwind due to the high P/E and very low dividend yield.
Positive Factors
Steady Revenue Growth
Consistent revenue expansion indicates resilient demand for the company’s chemical intermediates and specialty products. Continued top-line growth can support operating scale, customer development, and reinvestment in manufacturing capacity over the next several quarters.
Negative Factors
Persistent Negative Cash Generation
Persistent negative operating and free cash flow signals weak conversion of reported business activity into cash. This can increase reliance on cash reserves or financing to support operations and investment, reducing flexibility if working-capital pressure continues.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Consistent revenue expansion indicates resilient demand for the company’s chemical intermediates and specialty products. Continued top-line growth can support operating scale, customer development, and reinvestment in manufacturing capacity over the next several quarters.
Read all positive factors

Shivalik Rasayan Ltd (SHIVALIK) vs. iShares MSCI India ETF (INDA)

Shivalik Rasayan Ltd Business Overview & Revenue Model

Company Description
Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecti...
How the Company Makes Money
Shivalik Rasayan Ltd primarily makes money by manufacturing and selling chemical intermediates and specialty chemicals to industrial customers on a B2B basis. Revenue is generated through (1) sale of manufactured chemical products (the core stream...

Shivalik Rasayan Ltd Financial Statement Overview

Summary
Steady revenue growth and a conservatively levered balance sheet support the fundamentals, but the profile is materially weakened by consistently negative free cash flow and negative operating cash flow in recent years, alongside thinner margins versus earlier peaks.
Income Statement
66
Positive
Balance Sheet
78
Positive
Cash Flow
22
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue3.75B3.68B3.12B2.72B2.34B2.07B
Gross Profit1.45B1.00B805.70M1.32B1.20B1.13B
EBITDA466.35M498.42M485.11M461.64M493.13M504.71M
Net Income136.70M121.36M166.96M127.17M212.35M256.06M
Balance Sheet
Total Assets0.008.19B7.34B6.92B5.78B4.88B
Cash, Cash Equivalents and Short-Term Investments343.68M343.68M279.69M377.38M306.71M707.58M
Total Debt0.001.14B938.83M859.67M655.12M411.22M
Total Liabilities-5.99B2.20B1.98B1.85B1.59B1.24B
Stockholders Equity5.99B5.99B4.15B3.90B3.10B2.87B
Cash Flow
Free Cash Flow-267.77M-581.61M-294.37M-757.31M-821.81M-138.32M
Operating Cash Flow-168.43M-414.68M-86.05M-80.75M-189.49M111.34M
Investing Cash Flow-157.64M-233.18M-208.31M-743.08M-707.72M-233.56M
Financing Cash Flow514.76M711.84M196.69M894.49M496.34M782.07M

Shivalik Rasayan Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price358.75
Price Trends
50DMA
309.97
Positive
100DMA
273.54
Positive
200DMA
286.07
Positive
Market Momentum
MACD
31.02
Positive
RSI
62.47
Neutral
STOCH
65.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Positive. The current price of 358.75 is below the 20-day moving average (MA) of 373.92, above the 50-day MA of 309.97, and above the 200-day MA of 286.07, indicating a bullish trend. The MACD of 31.02 indicates Positive momentum. The RSI at 62.47 is Neutral, neither overbought nor oversold. The STOCH value of 65.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:SHIVALIK.

Shivalik Rasayan Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
₹5.67B19.47―0.49%11.71%79.88%
62
Neutral
₹2.72B17.66―1.56%3.55%-21.35%
62
Neutral
₹2.48B13.18―0.13%12.41%51.78%
60
Neutral
₹6.32B45.45―0.13%14.88%-9.46%
57
Neutral
₹24.89B34.82―0.13%27.57%135.05%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
49
Neutral
₹3.80B18.31―0.26%17.28%-10.19%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:SHIVALIK
Shivalik Rasayan Ltd
392.55
-43.81
-10.04%
IN:BODALCHEM
Bodal Chemicals Limited
192.00
129.33
206.37%
IN:DICIND
DIC India Limited
610.00
97.85
19.11%
IN:MANORG
Mangalam Organics Ltd
437.30
-115.90
-20.95%
IN:PODDARMENT
Poddar Pigments Limited
257.00
-4.91
-1.88%
IN:SRD
Shankar Lal Rampal Dye-Chem Ltd.
39.30
-25.84
-39.66%

Shivalik Rasayan Ltd Corporate Events

Shivalik Rasayan Publishes EGM Voting Results, Highlights Governance Focus
Aug 22, 2026
Shivalik Rasayan Limited disclosed the voting results of its Extraordinary General Meeting held on August 20, 2026 in Dehradun, in line with SEBI listing requirements. The meeting saw participation from promoters and a sizeable public shareholder ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 17, 2026